Naloxone for narcotic-exposed newborn infants. - Wikidata - awgldk - TriplyDB

Naloxone for narcotic-exposed newborn infants.

Naloxone for narcotic-exposed newborn infants.

http://www.wikidata.org/entity/Q30880113

about

Naloxone for opiate-exposed newborn infants Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Evidence Based Neonatology : What is New? (Cochrane Reviews Scan).

P2860

Q24200719-B05210B9-AF1E-4106-83E0-7C7457F8E310 Q24247454-AB5CDDFD-608D-4338-AA67-8403B7A85800 Q42131154-C21981D2-9EEE-452E-8E00-F54141FD03CA

P2860

Naloxone for narcotic-exposed newborn infants.

http://www.wikidata.org/entity/Q30880113

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Naloxone for narcotic-exposed newborn infants.

@ast

Naloxone for narcotic-exposed newborn infants.

@en

type

label

Naloxone for narcotic-exposed newborn infants.

@ast

Naloxone for narcotic-exposed newborn infants.

@en

prefLabel

Naloxone for narcotic-exposed newborn infants.

@ast

Naloxone for narcotic-exposed newborn infants.

@en

P1433

Q30880113-B967AE1A-EA4F-4D0B-8CBC-50D10F12FC6B

P1476

Q30880113-2FC18DF7-DA04-4F84-8963-296B27421B2C

P2093

Q30880113-97868030-0569-4702-A589-D5573722A021

Q30880113-B3BE4557-D12C-4871-A831-EDDC126591E2

P2860

Q30880113-17088FAD-8ED4-4271-9A59-C6884F5B3030

Q30880113-1AA4F8E8-B067-4E32-B004-D3BD8FB0C3D6

Q30880113-2BFA14AE-AA2C-409D-873C-62760123E0FA

Q30880113-609D2102-A4F5-4402-AD93-CCC4D31D3B8B

Q30880113-7C8B6E4F-541A-491F-A4D5-521F3E525500

Q30880113-7CD06647-246E-4894-934B-92E43E7413E4

Q30880113-8A6EDC94-0E5C-4FB2-98AE-404D03F874DE

Q30880113-979E6FE1-66DF-4E0F-83BB-9B64A63EB0E5

Q30880113-B944D567-A8C8-490A-8C0D-AD1185E033EC

Q30880113-CBF1C99C-A5BC-4113-AEB5-8644929BE49C

P304

Q30880113-939E8A7B-5979-4536-8B37-98698E45F522

P31

Q30880113-3392267e-d560-451f-8110-15c93a6bc45d

Q30880113-AA551766-D8D8-428B-8338-2D2D81F0C13E

P356

Q30880113-9A15751D-BB81-4445-8053-E33651DF13DE

P433

Q30880113-FA1C0878-A955-4C5F-B821-A98B2DF9D81C

P577

Q30880113-53B2B79B-A8AE-44F9-B227-58071DFF4743

P698

Q30880113-D1C4DD23-7136-4C9A-B779-5F340DF1A5B9

P356

14651858.CD003483

P1433

Cochrane Database of Systematic Reviews

P1476

Naloxone for narcotic-exposed newborn infants.

@en

P2093

P W Fowlie

http://www.w3.org/2001/XMLSchema#string

W McGuire

http://www.w3.org/2001/XMLSchema#string

P2860

Role of naloxone in newborn resuscitation.

Effects of pethidine and its antagonists on the newborn.

Prenatal experience with milk: fetal behavior and endogenous opioid systems.

Clinical investigations of the influence of various naloxone doses on the newborn.

Use of nalotone to to reverse narcotic respiratory depression in the newborn infant.

Naloxone reversal of mild neurobehavioral depression in normal newborn infants after routine obstetric analgesia.

Neonatal respiration, feeding and neurobehavioural state. Effects of intrapartum bupivacaine, pethidine and pethidine reversed by naloxone.

Naloxone hazard in infant of opioid abuser.

Effects of naloxone on newborn infant behavior after maternal analgesia with pethidine during labor.

Effects of naloxone on pethidine-induced neonatal depression. Part II--Intramuscular naloxone.

P304

CD003483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD003483

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12519598

http://www.w3.org/2001/XMLSchema#string